MedTwenty

Investor Intelligence

Spark Capital

Venture capital · Boston, United States

Lead investor in the Abridge Series D.

Assets under management$9bn
Healthcare deals3
Capital deployed$390m
FocusEnterprise software and AI

Recent deals

DateCompanyRoundAmount
Sep 2026AbridgeSeries D$340m

Exits

Complete portfolio and co-investor network

Professional membership unlocks the full portfolio record, co-investment graph and screening across 5,000+ investor profiles.

Upgrade